Immune Biomarkers in the Prediction of Future Myocardial Infarction in People with HIV.
A retrospective case control analysis determined that following adjustment for hsCRP, presence of traditional cardiovascular risk factors and CD4/CD8 T cell ratio, higher lipopolysaccharide binding protein (LBP) was associated with future myocardial infarction in HIV. LBP may be a novel marker of cardiovascular risk with specific utility in HIV.